Showing results for "BIOS" in Money & Finance

"An essential read for anyone committed to understanding the technologies that will define our future." CHRISTIAN ANGERMAYER, BIOTECH ENTREPRENEUR AND FOUNDER OF APEIRON INVESTMENT GROUP Welcome to the biotech revolution In the last century, technology has transformed the human experience across...

Like it or not, everyone has a brand.Your brand is a fancy way of saying what you're known for. Essentially, it's what people say about you when you're not in the room. Whether you're a founder, a senior exec, or just starting out in your career, From Unknown to Unforgettable will show you exactly what you need to build a personal brand that goes beyond the bio.

This isn’t just the fluffy s*** you see on social media.Join me Sophie Milliken, Founder and CEO at modern PR agency Moja, along with my industry-expert guests, as I show you how to raise your profile.Each week I cover topics like, awards, PR, speaking, social media and of course, the power of podcasting – essentially all the good stuff. Whether you’re a budding start-up or a seasoned entrepreneur, this podcast will help you get known in your industry.Let’s go Beyond the Bio.Thank you for listening. Follow the podcast so you don't miss future episodes and leave me a review so I can ...

Hosted by an operator, not a journalist. Biotech CEOs on the BIZ with Dr. Kambiz! is a conversation series with the founders and chief executives building the next generation of biotech companies. Host Kambiz Shekdar, PhD, is Founder and CEO of Secondcell Bio. He asks the questions a fellow operator would ask. Each episode is recorded in person, one CEO at a time, covering the science, the business, and the parts of the job nobody puts in a press release. Fundraising, hiring, partnerships, platform strategy, and the decisions that never make it into a deck. New episodes weekly, powered by ...

The Biotech Startups Podcast by Excedr features weekly conversations with founders, scientists, and investors driving biotech innovation. Host Jon Chee dives into the challenges of building biotech startups, from pre-seed to IPO. New episodes every Monday and Thursday.

The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, regulatory, and commercial challenges you’ll face as you navigate your company from an idea to success in the clinic and beyond. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by Life Science Connect.

Link na Bio é o podcast da Amazon Influencers que revela os bastidores da criação de conteúdo. Creators compartilham histórias reais sobre começos, desafios, erros, aprendizados e viradas de chave, em conversas leves, honestas e sem fórmula pronta. Em cada episódio, você encontra dicas práticas, troca experiências com quem vive a creator economy e acompanha um Unboxing Amazon com produtos e descobertas para inspirar novos conteúdos. Dê o play e descubra o que existe por trás da influência em ação. Link na Bio. Um podcast por Amazon Influencers.

This is She Leads Biotech, a podcast where we have real conversations with women leading the charge in innovation, research, and entrepreneurship in the bioscience space. Each episode offers a candid look at what it takes to succeed in a historically male-dominated field, and how to lean into your strengths to get where you want to go. We’re not just talking about the science; we’re getting to know the people behind the job titles!

Thrive Bio explores how probiotic and enzyme-based cleaning is replacing harsh chemicals across hospitality, mining, education, and facilities management. Each episode breaks down a real case study — the problem, the switch, and the measurable results: water saved, callouts reduced, odours eliminated, costs avoided. Practical insights for operators, facilities managers, and procurement teams who want cleaner sites and a lighter environmental footprint. https://thrivebio.com.au/

What happens when you mix a disco-dancin' podcaster with some of the brightest minds in biotech? You get Talk BIO to Me. Recorded live at SynBioBeta, this interview series takes you inside the world of synthetic biology through conversations with pioneering scientists, founders, investors, and AI innovators building the future of life.

Demystifying life sciences, healthcare and market research, one episode at a time.

Clarity. Confidence. Momentum. What if every decision you made could bring you closer to the life you truly want? In today’s world of constant noise, endless choices, and overthinking, it’s easy to get stuck in doubt. The Future of Decisive Choice offers a breakthrough path forward, showing you how to combine the wisdom of your intuition with the precision of artificial intelligence to make decisions that feel aligned, empowered, and unstoppable. Author Karen Romine introduces a transformational approach that goes beyond quick fixes.

Biotech—it's complicated. A successful product launch requires grit, determination, and clear direction. But let’s be real, the path to launch isn’t a straight one. There are curves, hard turns, and dead ends. Here’s the good news, you don’t have to navigate the complexities alone. Welcome to The Emerging Biotech Leader, where we help biotech leaders maximize the value of their therapeutics from clinical development to product launch.

I’m Terra Csotty — entrepreneur, host, and passionate connector — and I believe that behind every achievement, there’s a journey filled with lessons, courage, and connection. This show isn’t about filters, highlights, or titles — it’s about the real stuff: the risks, the growth, and the relationships that shape who we become. You’ll hear from leaders, creators, and visionaries who show us that success isn’t just about what you achieve — it’s about how you show up and stay true to who you are. Because success isn’t just what you do — it’s who you are beyond the bio. ...

Nachhaltig nachgefragt ist ein Podcast der BIO HOTELS, einer Wertegemeinschaft von über 50 Hoteliers in Europa, die sich maximaler Nachhaltigkeit und höchsten Qualitätsstandards verschrieben haben. Die Berliner Journalistin Julia Hackober spricht zweimal im Monat mit Menschen, die ein BIO HOTEL leiten oder in einem Bio Hotel arbeiten. Ihr erfahrt, wie ein umweltfreundlicher Urlaub aussehen kann, was ein nachhaltiges Hotel ausmacht, welche Herausforderungen zu bewältigen sind, wenn ein Hotel wirklich bio werden soll und wieviel Durchhaltevermögen und Überzeugungen auf dem Weg in eine ...

A weekly news update on the latest trends in the biotech sector, where we cut through the noise and focus on the signals that actually matter for biotech operators, innovators, investors and clinical teams.An audio version of "The Biotech Pulse" weekly newsletter published on LinkedIn : Subscribe on LinkedIn https://www.linkedin.com/build-relation/newsletter-follow?entityUrn=7404348538391834624

MG188 Bio là trang nhà cái cá cược trực tuyến uy tín tại Việt Nam cung cấp các sản phẩm đa dạng như: cá cược thể thao (bóng đá, bóng rổ, tennis,..), sòng live casino, xổ số online, đá gà trực tiếp, bắn cá đổi thưởng, quay slot game,…Nhà cái Mg188 được cấp phép và điều hành bởi tập đoàn cá cược uy tín CUBET LIMITED. Đạt giấy phép cá cược online cấp bởi tổ chức uy tín PAGCOR và Isle of Man Gambling Supervision Commission. Địa chỉ: 194 Tân Sơn, Phường 12, Gò Vấp, Thành phố ...

The Bio Report podcast, hosted by award-winning journalist Daniel Levine, focuses on the intersection of biotechnology with business, science, and policy.

The ecosystem view of longevity science, wellness industry, biomedicines and everything fuzzy in between. Definition driven, research news , first-principle grounded multi-AI agentic discussions

Lucas and Luna step into the clean, cool world of biotechnology startups, where drug discovery meets the harsh realities of FDA approvals and venture capital. Each episode takes a single biotech company—from Moderna to a tiny CRISPR spinout—and dissects its science, its business model, and the regulatory path that determines its fate. Lucas brings the numbers: clinical trial phases, patent cliffs, burn rates. Luna presses on the human stories: the researchers betting careers on a single molecule, the patients waiting for therapies that might never come. They don't celebrate hype; they ask ...